Form 4 for IDXX Idexx Laboratories
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-14 · accession 0000874716-24-000037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-16 | 2024-02-14 | IDXX | Johnson Michael Perkins | EVP, CHRO | M - OptEx | $0.00 | +176 | 243.34 | +261% | $0 |
| D | 2024-02-16 | 2024-02-14 | IDXX | Johnson Michael Perkins | EVP, CHRO | F - Tax | $560.56 | -60 | 183.34 | -25% | -$33.6K |
| DM | 2024-02-16 | 2024-02-14 | IDXX | Johnson Michael Perkins | EVP, CHRO | A - Grant | $0.00 | +4,024 | 3,132 | New | $0 |
| D | 2024-02-16 | 2024-02-14 | IDXX | Johnson Michael Perkins | EVP, CHRO | M - OptEx | $0.00 | -176 | 528 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-14 | M | A | 176 | $0.00 | 243.34 | D | — | — | (F1) Includes a total of 51.542 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2023, June 30, 2023, September 29, 2023 and December 29, 2023. |
| 2 | Common | Common Stock | 2024-02-14 | F | D | 60 | $560.56 | 183.34 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-02-14 | A | A | 714 | $0.00 | 714 | D | $0.00 · — to — | 714 Common Stock | (F4) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025. |
| 4 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 176 | $0.00 | 528 | D | — · — to — | 176 Common Stock | (F5) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024. |
| 5 | Derivative | Incentive Stock Option (right-to-buy) | 2024-02-14 | A | A | 178 | $0.00 | 178 | D | $560.56 · — to 2034-02-13 | 178 Common Stock | (F3) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028. |
| 6 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2024-02-14 | A | A | 3,132 | $0.00 | 3,132 | D | $560.56 · — to 2034-02-13 | 3,132 Common Stock | (F2) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025. |